Shandong Freda Pharmaceutical Group

Shandong Freda Pharmaceutical Group is a leading Chinese pharmaceutical and health industry group specializing in the research, development, and manufacturing of hyaluronic acid-based products. Founded in 1991 and headquartered in Jinan, the company operates across pharmaceuticals, medical devices, and high-end cosmetics. It is widely recognized for its expertise in fermentation technology and is a major global supplier of sodium hyaluronate. The group's portfolio includes well-known brands such as Rellet and Dr. Alva, focusing on ophthalmology, orthopedics, and dermatology. As a subsidiary of the Lushang Group, it maintains a significant presence in the Chinese market and exports products to over 70 countries. The company is publicly traded on the Shanghai Stock Exchange under the name Freda (600223.SH) following a major corporate restructuring.